TNFATNF Pharmaceuticals Inc.


$ 1.24 $ 0.04 (3.31 %)    

Monday, 16-Sep-2024 15:59:31 EDT
QQQ $ 472.58 $ -1.98 (-0.42 %)
DIA $ 416.26 $ -0.64 (-0.15 %)
SPY $ 562.20 $ -1.66 (-0.29 %)
TLT $ 99.62 $ -0.70 (-0.7 %)
GLD $ 235.53 $ -2.66 (-1.12 %)
$ 1.25
$ 1.19 x 204
$ 1.23 x 150
-- - --
$ 1.19 - $ 19.20
16,024
na
na
$ 2.09
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

MYMD-1® development to continue through fully funded mid-stage clinical trialsClinical study of MYMD-1 in sarcopenia/frailty me...

Core News & Articles

New name and stock symbol represents therapeutic focus on inhibiting TNF-alpha to regulate the immuno-metabolic system

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION